Novanta Inc (NOVTU) stock
Close on Nov 2, 2026Market cap $5.51BP/E 93.4Yield –
Novanta Inc grew revenue 7.6% to $1.03B over the twelve months to Jul 3, 2026. Operating income fell 13.4% to $92.28M, moving the operating margin from 11.1% to 9.0%. Free cash flow was $114.28M, down 3.0% from a year earlier. At the latest close the market valued the company at $5.51B, 93.4 times its earnings.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jul 3, 2026
Valuation
- Market cap
- $5.51B
- P/E ratio
- 93.4
- Price to sales
- 5.35
- Price to book
- 3.41
- Dividend yield
- –
- Free cash flow yield
- 2.07%
Fundamentals
- Revenue
- $1.03B
- Net income
- $61.76M
- EPS, diluted
- $1.56
- Free cash flow
- $114.28M
- Book value per share
- $39.27
- Diluted shares
- 41M
Trading
- Next earnings
- Nov 2, 2026 (estimated, after the close)
- Previous close
- $60.75
- Open
- $62.89
- Day's range
- $60.91 – $62.89
- Volume
- 11,717
- Average volume (20 days)
- 50,367
- Beta (5 years)
- 1.63
- 52-week range
- $98.27 – $176.38
- RSI (14 days)
- 53.1
- Volatility (1 year)
- 51.8%
- Relative volume
- 0.96×
- WACC
- 12.8%
Market cap history
Month-end market cap since 2010, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 2, 2026. The S&P 500 is measured by the SPY fund.
| Period | NOVTU | S&P 500 | Difference | NOVTU per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -3.1% | -2.3% | −0.9 pts | ||
| 3 months | -0.0% | +0.9% | −1.0 pts | ||
| Year to date | +15.4% | +11.2% | +4.3 pts |
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Novanta filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Update
- News
- Update
- Update
- Results
About Novanta
Miscellaneous Electrical Machinery, Equipment & Supplies
Novanta Inc. provides technology solutions and specialized equipment across the healthcare and industrial sectors. The company operates through two primary segments: Medical Solutions and Automation Enabling Technologies. Its offerings include motion solutions, developed technologies, and systems supporting advanced surgery, precision medicine, robotics, automation, and precision manufacturing. The company delivers its products and technical solutions to original equipment manufacturers and industrial customers across global commercial markets.
Company profile, executives and historyNovanta stock: common questions
What is Novanta's stock price?
NOVTU closed at $60.95 on Nov 2, 2026, up 0.33% on the day. Over the past 52 weeks it traded between $98.27 and $176.38.
What is Novanta's market cap?
Novanta was worth $5.51B at the close on Nov 2, 2026: the share price times the diluted shares outstanding.
What is NOVTU's P/E ratio?
NOVTU trades at 93.4 times earnings, based on diluted earnings per share of $1.56 over the twelve months to Jul 3, 2026.
How much revenue does Novanta make?
Novanta reported revenue of $1.03B for the twelve months to Jul 3, 2026, up 7.6% from a year earlier.
Does Novanta pay a dividend?
No. Novanta has not paid a cash dividend over the last twelve months.
When does Novanta report earnings next?
Novanta is expected to report Q3 FY2026 results on Nov 2, 2026, after the close. The date is estimated from its past reporting pattern until the company confirms it.
Who are Novanta's competitors?
Companies most similar to Novanta by business, industry and size include ENS, CAE, FLNC, MVST, CHPT.